As per this study the Global Scopolamine Market was valued USD XX MN (by revenue) in 2022 and is anticipated to reach USD XX MN by 2030 with a CAGR of 7.1%.
Scopolamine or hyoscine is the alkaloid drug prescribed to treat postoperative nausea and vomiting and prevent motion sickness. It is anticholinergics that target CNS to create calming effect on gut and stomach muscles. It can be introduced into patients body through mouth, subcutaneously, opthalmically, intravenously and by transdermal patch. It is also used to dry up salivary secretions and dilate bronchi and pupil in case of any medical procedures.
Market Dynamics
An increasing number of domestic and international travelers undergoing motion sickness is driving the market growth. Use of scopolamine to treat stomach problem, muscle spams and Parkinson like medical conditions is further boosting the market growth. Also, growing nmber of surgeries leading into rise in demand of product to control postoperative nausea and hyper salivary secretion is again pushing the market growth uphill. However, stringent regulation on production in various regions is likely to hinder the market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of scopolamine.
Market Segmentation
The broad scopolamine market has been sub-grouped into dosage form and distribution channel. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Dosage Form
By Distribution Channel
Regional Analysis
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for scopolamine in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Scopolamine Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the Scopolamine market include Pfizer Inc., Baxter International Inc., Myungmoon Pharm Co Ltd., Phytex Australia, Caleb Pharmaceuticals, Inc., GlaxoSmithKline Plc., Centroflora-Cms, Alkaloids of Australia, Perrigo Company Plc., and Novartis International AG, among Others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . SCOPOLAMINE – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Dosage Form
3.7.2 Market Attractiveness Analysis By Distribution Channel
3.7.3 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL SCOPOLAMINE MARKET ANALYSIS BY DOSAGE FORM
5.1 Overview by Dosage Form
5.2 Historical and Forecast Data
5.3 Analysis by Dosage Form
5.4 Injectables Historic and Forecast Sales by Regions
5.5 Tablets Historic and Forecast Sales by Regions
5.6 Transdermal Patches Historic and Forecast Sales by Regions
5.7 Other Dosage Forms Historic and Forecast Sales by Regions
6 . GLOBAL SCOPOLAMINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6.1 Overview by Distribution Channel
6.2 Historical and Forecast Data
6.3 Analysis by Distribution Channel
6.4 Hospital Pharmacies Historic and Forecast Sales by Regions
6.5 Retail Pharmacies Historic and Forecast Sales by Regions
6.6 Other Distribution Channels Historic and Forecast Sales by Region...
